Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    State seeks to block Christa Pikes attorneys from inspecting execution drug

    November 19, 2026

    Here Are the 2026 National Book Awards Winners

    November 19, 2026

    Microsoft CEO Satya Nadella explains why he asked 60K employees to quit | TechCrunch

    November 19, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Technology»Visby Medical tests positive for a Series E extension at $1B+ valuation – TechCrunch
    Technology

    Visby Medical tests positive for a Series E extension at $1B+ valuation – TechCrunch

    By AdminJuly 1, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Visby Medical tests positive for a Series E extension at $1B+ valuation – TechCrunch

    [ad_1]

    Visby Medical tests positive for a Series E extension at $1B+ valuation – TechCrunch

    Medical diagnostics company Visby Medical raised $100 million in a Series E round earlier this year. Today, the company told me it extended that round by an additional $35 million at the same valuation as the rest of the round. This financing will enable Visby Medical to scale production capacity from tens to hundreds of thousands of monthly tests. It will also further expand its product lineup to include COVID + influenza A/B combination testing, antimicrobial resistance panels, and deliver at-home PCR diagnostics to consumers.

    “The valuation is just over $1B post-money,” a spokesperson for the company told TechCrunch over email. “The extension is at the same valuation as the rest of the round, which we think demonstrates that these are long-term investors, not influenced by short-term fluctuations in the public markets.”

    The company told me it consciously sought out investors that would be eager to continue to invest long-term. The original $100 million was led by Ping An Voyager Partners and joined by the Healthcare of Ontario Pension Plan (HOOPP). The round also included participation by existing investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and Nissim Capital.
    The extension round of an additional $35 million was led by Lightrock, who joined existing Series E investors including John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and J Ventures.

    “At Visby Medical, we are revolutionizing patient care by developing diagnostics that healthcare providers can use to test for any infection at anytime, anywhere,” said Visby Medical Founder and CEO Adam de la Zerda, PhD in a statement to TechCrunch. “Especially during these times of market slowdown, our investors have shown significant confidence in Visby’s innovative technology and mission. This funding will enable us to further our goal to provide the world’s first instrument-free handheld PCR platform to accurately and rapidly test for a variety of serious infections to anyone who needs it.”

    Visby’s PCR diagnostic technology is being developed in multiple therapeutic areas and is aimed to address a critical and growing global need: to combat the significant rise in infectious diseases, including on-the-spot STI rapid testing solutions.

    The financing goes to show that there’s still money out there, and it’s encouraging to see that companies are more forthcoming about announcing both round extensions — which traditionally have been frowned upon by the investment community — and valuations as part of their funding journey.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleIVF: Why two-thirds of embryos created via in vitro fertilisation suddenly stop developing
    Next Article Ep. 496 — Kellyanne Conway – The Axe Files with David Axelrod

    RELATED POSTS

    Microsoft CEO Satya Nadella explains why he asked 60K employees to quit | TechCrunch

    November 19, 2026

    More banks says customers using AI agents are on their own — even if they get hacked | TechCrunch

    November 18, 2026

    Nvidias startup stakes ballooned to $65B, but Huangs exit puts future deals in doubt | TechCrunch

    November 18, 2026

    Protons Lumo, a privacy-focused alternative to ChatGPT and Claude, arrives on desktop | TechCrunch

    November 17, 2026

    Cybersecurity AI startup Corma reaches $1B valuation in about 3 months | TechCrunch

    November 17, 2026

    Jordan Belforts new AI voice startup, Tone, wants to sell like the Wolf of Wall Street | TechCrunch

    November 16, 2026
    latest posts

    State seeks to block Christa Pikes attorneys from inspecting execution drug

    Tennessee is seeking to block Christa Pike’s attorneys from accessing the lethal injection drug used…

    Here Are the 2026 National Book Awards Winners

    November 19, 2026

    Microsoft CEO Satya Nadella explains why he asked 60K employees to quit | TechCrunch

    November 19, 2026

    Waxahatchee Is Hosting a Songwriting Workshop

    November 18, 2026

    More banks says customers using AI agents are on their own — even if they get hacked | TechCrunch

    November 18, 2026

    Esosa Gabrielle Delivers a Powerful Musical Confession with Her Stunning New Single “Guilty”

    November 18, 2026

    Episode 3: Wild Horse Nine and Possible Love

    November 18, 2026
    Categories
    • Books (1,616)
    • Business (6,521)
    • Cover Story (17)
    • Film (6,455)
    • Lifestyle (4,498)
    • Music (6,531)
    • Politics (6,506)
    • Science (5,861)
    • Technology (6,458)
    • Television (6,153)
    • Uncategorized (3)
    • US News (6,505)
    popular posts

    Needles Found In Massachusetts Halloween Candy – Police Warn ‘All Trick-Or-Treat Candy Should Be Inspected’

    [ad_1] Police in Massachusetts are sounding the alarm after needles were found in Halloween candy,…

    Best Indoor Garden Systems I’ve Been Testing All Year (2026)

    September 14, 2026

    Wendy Cole Guests On TriVersity Talk! With Host Wendy Stuart 7 PM ET Wednesday, September 23rd, 2026

    September 18, 2026

    CDC encourages those eligible for a second COVID booster to wait as Politico reports vaccines are rationed

    May 13, 2022
    Archives
    Browse By Category
    • Books (1,616)
    • Business (6,521)
    • Cover Story (17)
    • Film (6,455)
    • Lifestyle (4,498)
    • Music (6,531)
    • Politics (6,506)
    • Science (5,861)
    • Technology (6,458)
    • Television (6,153)
    • Uncategorized (3)
    • US News (6,505)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Esosa Gabrielle Delivers a Powerful Musical Confession with Her Stunning New Single “Guilty”

    November 18, 2026

    Episode 3: Wild Horse Nine and Possible Love

    November 18, 2026

    Immigration arrests go on unabated despite Trumps misgivings after the GOPs midterm wipeout

    November 18, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT